Ashwagandha Leaves Banned: FSSAI Cites Safety Risks

The Food Safety and Standards Authority of India (FSSAI) has prohibited the use of ashwagandha leaves and their extracts in various food products, including supplements and nutraceuticals. This decision, based on safety concerns raised by the Union Ministry of Ayush, aligns with Schedule IV regulations which permit only roots and their extracts.

Manufacturers were found using ashwagandha leaves, prompting the FSSAI to clarify that such usage is not permitted. The advisory specifies that ashwagandha leaves contain higher levels of withanolides, like withaferin-A, which can lead to adverse health effects including liver toxicity and gastrointestinal distress.

State authorities have been directed to enforce strict vigilance and take legal action against non-compliant businesses. The FSSAI also mandates clear labeling of the plant part used, enhancing consumer transparency. Experts emphasize this is a plant-part-specific regulation, not a ban on ashwagandha itself, as root extracts remain permissible and aligned with traditional Ayurvedic practices.